Perth, Feb 2, 2015 - (ABN Newswire) - PhytoTech Medical Limited (ASX:PYL), wishes to advise that Ross Smith has resigned as a director effective immediately.
Peter Wall, the Chairman of the Company said, "Ross has been instrumental in bringing together an outstanding team to manage the business moving forward. The Company would not be where it is today without Ross' hard work and perseverance."
Mr Smith said "Having achieved what the majority of people said couldn't be done in listing Australia's first Medical Cannabis company, I am stepping down from the Board confident that the world class team we brought together and the Company will go on to become a huge success. I will continue to stay living in Israel while looking for the next big thing in biotechnology and technology."
The Board would like to express its thanks to Mr Smith for his past service and contributions to the Company to date.
WEB: Changes to Management
About: PhytoTech Medical Limited
PhytoTech Medical (ASX:PYL) is a medical cannabis company, which aims to commercialize Medical Grade Cannabis (MGC) and high potential cannabis based therapeutics products to the rapidly growing international market with regulated medical cannabis legislation. With research facilities located in Israel, a global leader in medical cannabis research, the Company is strategically positioned to become a key player in the global MGC market.
The Company is focused on the research, development and commercialization of products for administering MGC, and on new treatments utilizing MGC therapeutic components for various medical conditions. In addition, the Company aims to grow proprietary strains of MGC in California, Uruguay and other jurisdictions.
Help employers find you! Check out all the jobs and post your resume.
Peter Wall, the Chairman of the Company said, "Ross has been instrumental in bringing together an outstanding team to manage the business moving forward. The Company would not be where it is today without Ross' hard work and perseverance."
Mr Smith said "Having achieved what the majority of people said couldn't be done in listing Australia's first Medical Cannabis company, I am stepping down from the Board confident that the world class team we brought together and the Company will go on to become a huge success. I will continue to stay living in Israel while looking for the next big thing in biotechnology and technology."
The Board would like to express its thanks to Mr Smith for his past service and contributions to the Company to date.
WEB: Changes to Management
About: PhytoTech Medical Limited
PhytoTech Medical (ASX:PYL) is a medical cannabis company, which aims to commercialize Medical Grade Cannabis (MGC) and high potential cannabis based therapeutics products to the rapidly growing international market with regulated medical cannabis legislation. With research facilities located in Israel, a global leader in medical cannabis research, the Company is strategically positioned to become a key player in the global MGC market.
The Company is focused on the research, development and commercialization of products for administering MGC, and on new treatments utilizing MGC therapeutic components for various medical conditions. In addition, the Company aims to grow proprietary strains of MGC in California, Uruguay and other jurisdictions.
Help employers find you! Check out all the jobs and post your resume.
